![]() |
Volumn 343, Issue 21, 2000, Pages 1514-1519
|
Intrathecal methylprednisolone for intractable postherpetic neuralgia
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DICLOFENAC;
INTERLEUKIN 8;
LIDOCAINE;
METHYLPREDNISOLONE;
ADULT;
AGED;
ARTICLE;
CEREBROSPINAL FLUID ANALYSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DISEASE DURATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG USE;
FEMALE;
FOLLOW UP;
HUMAN;
INTRACTABLE PAIN;
MAJOR CLINICAL STUDY;
MALE;
PAIN ASSESSMENT;
POSTHERPETIC NEURALGIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
AGED;
ANESTHETICS, LOCAL;
ANTI-INFLAMMATORY AGENTS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DICLOFENAC;
DRUG THERAPY, COMBINATION;
FEMALE;
HERPES ZOSTER;
HUMANS;
INJECTIONS, SPINAL;
INTERLEUKIN-8;
LIDOCAINE;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
NEURALGIA;
PAIN;
PAIN MEASUREMENT;
SINGLE-BLIND METHOD;
|
EID: 0034707108
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200011233432102 Document Type: Article |
Times cited : (303)
|
References (33)
|